vimarsana.com

uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington's Disease

uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington's Disease

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Amsterdam ,Noord Holland ,Netherlands ,Mariae Cantor ,Sarah Tabrizi ,Chiara Russo ,Ricardo Dolmetsch ,Tom Malone ,Cure Huntington Disease Initiative ,Securities Exchange ,Phasei Ii Clinical Program ,Huntington Disease Center ,University College London ,Qure Announces Update ,Neurofilament Light Chain ,Total Motor Score ,Total Functional Capacity ,Unified Huntington ,Disease Rating Scale ,Disease Center ,Data Safety Monitoring Board ,Cure Huntington ,Disease Initiative ,Diagnostic Classification Level ,Disease Rating ,Motor Score ,Functional Capacity ,Total Motor ,Plight Chain ,Cerebrospinal Fluid ,Conference Call ,Qure Forward Looking ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Report ,Qure Contacts ,

vimarsana.com © 2020. All Rights Reserved.